Saudi Scientific Diabetes Society Position Statement: Management of Diabetes Mellitus in the Pandemic of COVID-19

作     者：Abdulrahman Alshaikh Saud Alsifri Amani Alhozali Hala Mosli Tarif Zawawi Seraj Mira Emad R. Issak 

作者机构：Medicine Department King Abdulaziz University Jeddah KSA Endocrinology Department Alhada Armed Forces Hospital Taif KSA Independent Researcher Cairo Egypt 

出 版 物：《International Journal of Clinical Medicine》 (临床医学国际期刊（英文）)

年 卷 期：2020年第11卷第5期

页      面：199-206页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：COVID-19 Diabetes Mellitus Glycemic Target Blood Glucose Control 

摘      要：About 10% coronavirus (COVID-19) infected patients are with diabetes comorbidity. Also, diabetes promotes severe progression in COVID-19 patients. Diabetes comorbidity is associated with significant mortality in those people with COVID-19. In this position statement, the management of diabetes in cases of COVID-19, has been presented. The impact of diabetes on the morbidity and mortality of COVID-19, as well as both the target glucose level and the method of blood glucose control have been presented in details.